The initiation of coverage with a Buy rating and a specific price target of $21 by a reputable analyst firm like HC Wainwright & Co. is likely to positively impact the stock price of Aura Biosciences in the short term. This is because such ratings often influence investor sentiment and can lead to increased buying activity.